PRESCRIBING · PART D · 2024
Total Rx claims
1,449
Beneficiaries
—
Total drug cost
$28K
Distinct drugs
12
Brand share
4.5%
Top prescribed drugs
Gabapentin426 claims
Tizanidine Hcl378 claims
Pregabalin184 claims
Duloxetine Hcl172 claims
Doxepin Hcl66 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
27.5
Cost
68.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
Group
CROSS-REFERENCE